Mastabolan 200 Pharmaceutical Research Overview
Mastabolan 200 Pharmaceutical is a drostanolone enanthate injectable compound specifically manufactured for in-vitro research applications. This pharmaceutical-grade preparation contains drostanolone coupled with enanthate ester, creating a modified steroid molecule extensively studied in androgen receptor research. The compound belongs to the dihydrotestosterone (DHT) derivative class, offering researchers a unique tool for investigating androgenic pathways and receptor binding mechanisms. Laboratory studies have examined its structural properties and interaction profiles, making it valuable for researchers at Stroid UK Shop investigating advanced steroid chemistry and molecular behaviour patterns in controlled experimental conditions.
Research Applications and Mechanisms
Research teams utilise Mastabolan 200 Pharmaceutical to examine drostanolone enanthate’s molecular interactions within cellular environments. The enanthate ester modification extends the compound’s stability profile, allowing extended observation periods during experimental protocols. Studies have investigated its binding affinity at androgen receptors, comparing structural conformations against other DHT derivatives. Researchers analyse its enzymatic resistance properties, particularly regarding 5α-reductase and aromatase enzyme interactions. The compound serves as a reference standard when examining steroid metabolism pathways and receptor selectivity patterns. Comparative studies often utilise this preparation alongside other drostanolone enanthate preparations to evaluate pharmaceutical manufacturing differences and purity impacts on experimental outcomes.
Analytical Specifications and Storage
| Parameter | Specification |
|---|---|
| Active Compound | Drostanolone Enanthate |
| Concentration | 200mg/mL |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Storage Temperature | Room temperature, dry conditions |
| Formulation | Injectable solution |
| Research Grade | Pharmaceutical standard |
The preparation requires controlled storage conditions to maintain molecular integrity throughout research protocols. Store at room temperature in dry conditions away from direct light exposure. Researchers should verify analytical specifications including molecular weight and CAS number with supplier documentation before commencing experimental work. The injectable formulation provides consistent dosing accuracy for quantitative studies. Quality control protocols should include purity verification and contamination screening before use in sensitive analytical procedures. Research teams studying related compounds often cross-reference results with selective androgen receptor modulators and peptide research compounds to establish comparative molecular activity profiles.
Research Compliance and Laboratory Use
Mastabolan 200 Pharmaceutical is supplied exclusively for in-vitro research purposes and laboratory investigation only. This compound is not intended for human consumption, therapeutic application, or any clinical use. Research institutions must maintain proper documentation of experimental protocols and ensure compliance with relevant laboratory safety standards. All analytical work should be conducted in appropriate laboratory environments with suitable containment and disposal procedures. Researchers are responsible for verifying regulatory compliance within their jurisdiction before conducting experimental studies.
